A rapid ex vivo clinical diagnostic assay for Fas receptor-induced T lymphocyte apoptosis

Bernice Lo, Madhu Ramaswamy, Joie Davis, Susan Price, V. Koneti Rao, Richard M. Siegel, Michael J. Lenardo

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Deleterious mutations in genes involved in the Fas apoptosis pathway lead to Autoimmune Lymphoproliferative Syndrome (ALPS). Demonstration of an apoptosis defect is critical for the diagnosis and study of ALPS. The traditional in vitro apoptosis assay, however, requires a week of experimental procedures. Here, we show that defects in Fas-induced apoptosis in PBMCs can be evaluated directly ex vivo using multicolor flow cytometry to analyze the apoptosis of effector memory Tcells, a Fas-sensitive subset of PBMCs. This method allowed us to sensitively quantify defective apoptosis in ALPS patients within a few hours. Some ALPS patients (ALPS-sFAS) without germline mutations have somatic mutations in Fas specifically in double-negative αβ T cells (DNTs), an unusual lymphocyte population that is characteristically expanded in ALPS. Since DNTs have been notoriously difficult to culture, defective apoptosis has not been previously demonstrated for ALPS-sFAS patients. Using our novel ex vivo apoptosis assay, we measured Fas-induced apoptosis of DNTs for the first time and found that ALPS-sFAS patients had significant apoptosis defects in these cells compared to healthy controls. Hence, this rapid apoptosis assay can expedite the diagnosis of new ALPS patients, including those with somatic mutations, and facilitate clinical and molecular investigation of these diseases.

Original languageEnglish
Pages (from-to)479-488
Number of pages10
JournalJournal of Clinical Immunology
Volume33
Issue number2
DOIs
Publication statusPublished - 2013
Externally publishedYes

Fingerprint

CD95 Antigens
Autoimmune Lymphoproliferative Syndrome
Apoptosis
T-Lymphocytes
2,6-dinitrotoluene
Mutation
Germ-Line Mutation
Flow Cytometry

Keywords

  • Apoptosis
  • Autoimmune Lymphoproliferative syndrome
  • Diagnosis
  • Double-negative Tcells
  • Effectormemory Tcells
  • Fas

ASJC Scopus subject areas

  • Immunology and Allergy
  • Immunology

Cite this

Lo, B., Ramaswamy, M., Davis, J., Price, S., Rao, V. K., Siegel, R. M., & Lenardo, M. J. (2013). A rapid ex vivo clinical diagnostic assay for Fas receptor-induced T lymphocyte apoptosis. Journal of Clinical Immunology, 33(2), 479-488. https://doi.org/10.1007/s10875-012-9811-z

A rapid ex vivo clinical diagnostic assay for Fas receptor-induced T lymphocyte apoptosis. / Lo, Bernice; Ramaswamy, Madhu; Davis, Joie; Price, Susan; Rao, V. Koneti; Siegel, Richard M.; Lenardo, Michael J.

In: Journal of Clinical Immunology, Vol. 33, No. 2, 2013, p. 479-488.

Research output: Contribution to journalArticle

Lo, B, Ramaswamy, M, Davis, J, Price, S, Rao, VK, Siegel, RM & Lenardo, MJ 2013, 'A rapid ex vivo clinical diagnostic assay for Fas receptor-induced T lymphocyte apoptosis', Journal of Clinical Immunology, vol. 33, no. 2, pp. 479-488. https://doi.org/10.1007/s10875-012-9811-z
Lo, Bernice ; Ramaswamy, Madhu ; Davis, Joie ; Price, Susan ; Rao, V. Koneti ; Siegel, Richard M. ; Lenardo, Michael J. / A rapid ex vivo clinical diagnostic assay for Fas receptor-induced T lymphocyte apoptosis. In: Journal of Clinical Immunology. 2013 ; Vol. 33, No. 2. pp. 479-488.
@article{2254f96cf3984bd08dc93e374fdb864c,
title = "A rapid ex vivo clinical diagnostic assay for Fas receptor-induced T lymphocyte apoptosis",
abstract = "Deleterious mutations in genes involved in the Fas apoptosis pathway lead to Autoimmune Lymphoproliferative Syndrome (ALPS). Demonstration of an apoptosis defect is critical for the diagnosis and study of ALPS. The traditional in vitro apoptosis assay, however, requires a week of experimental procedures. Here, we show that defects in Fas-induced apoptosis in PBMCs can be evaluated directly ex vivo using multicolor flow cytometry to analyze the apoptosis of effector memory Tcells, a Fas-sensitive subset of PBMCs. This method allowed us to sensitively quantify defective apoptosis in ALPS patients within a few hours. Some ALPS patients (ALPS-sFAS) without germline mutations have somatic mutations in Fas specifically in double-negative αβ T cells (DNTs), an unusual lymphocyte population that is characteristically expanded in ALPS. Since DNTs have been notoriously difficult to culture, defective apoptosis has not been previously demonstrated for ALPS-sFAS patients. Using our novel ex vivo apoptosis assay, we measured Fas-induced apoptosis of DNTs for the first time and found that ALPS-sFAS patients had significant apoptosis defects in these cells compared to healthy controls. Hence, this rapid apoptosis assay can expedite the diagnosis of new ALPS patients, including those with somatic mutations, and facilitate clinical and molecular investigation of these diseases.",
keywords = "Apoptosis, Autoimmune Lymphoproliferative syndrome, Diagnosis, Double-negative Tcells, Effectormemory Tcells, Fas",
author = "Bernice Lo and Madhu Ramaswamy and Joie Davis and Susan Price and Rao, {V. Koneti} and Siegel, {Richard M.} and Lenardo, {Michael J.}",
year = "2013",
doi = "10.1007/s10875-012-9811-z",
language = "English",
volume = "33",
pages = "479--488",
journal = "Journal of Clinical Immunology",
issn = "0271-9142",
publisher = "Springer New York",
number = "2",

}

TY - JOUR

T1 - A rapid ex vivo clinical diagnostic assay for Fas receptor-induced T lymphocyte apoptosis

AU - Lo, Bernice

AU - Ramaswamy, Madhu

AU - Davis, Joie

AU - Price, Susan

AU - Rao, V. Koneti

AU - Siegel, Richard M.

AU - Lenardo, Michael J.

PY - 2013

Y1 - 2013

N2 - Deleterious mutations in genes involved in the Fas apoptosis pathway lead to Autoimmune Lymphoproliferative Syndrome (ALPS). Demonstration of an apoptosis defect is critical for the diagnosis and study of ALPS. The traditional in vitro apoptosis assay, however, requires a week of experimental procedures. Here, we show that defects in Fas-induced apoptosis in PBMCs can be evaluated directly ex vivo using multicolor flow cytometry to analyze the apoptosis of effector memory Tcells, a Fas-sensitive subset of PBMCs. This method allowed us to sensitively quantify defective apoptosis in ALPS patients within a few hours. Some ALPS patients (ALPS-sFAS) without germline mutations have somatic mutations in Fas specifically in double-negative αβ T cells (DNTs), an unusual lymphocyte population that is characteristically expanded in ALPS. Since DNTs have been notoriously difficult to culture, defective apoptosis has not been previously demonstrated for ALPS-sFAS patients. Using our novel ex vivo apoptosis assay, we measured Fas-induced apoptosis of DNTs for the first time and found that ALPS-sFAS patients had significant apoptosis defects in these cells compared to healthy controls. Hence, this rapid apoptosis assay can expedite the diagnosis of new ALPS patients, including those with somatic mutations, and facilitate clinical and molecular investigation of these diseases.

AB - Deleterious mutations in genes involved in the Fas apoptosis pathway lead to Autoimmune Lymphoproliferative Syndrome (ALPS). Demonstration of an apoptosis defect is critical for the diagnosis and study of ALPS. The traditional in vitro apoptosis assay, however, requires a week of experimental procedures. Here, we show that defects in Fas-induced apoptosis in PBMCs can be evaluated directly ex vivo using multicolor flow cytometry to analyze the apoptosis of effector memory Tcells, a Fas-sensitive subset of PBMCs. This method allowed us to sensitively quantify defective apoptosis in ALPS patients within a few hours. Some ALPS patients (ALPS-sFAS) without germline mutations have somatic mutations in Fas specifically in double-negative αβ T cells (DNTs), an unusual lymphocyte population that is characteristically expanded in ALPS. Since DNTs have been notoriously difficult to culture, defective apoptosis has not been previously demonstrated for ALPS-sFAS patients. Using our novel ex vivo apoptosis assay, we measured Fas-induced apoptosis of DNTs for the first time and found that ALPS-sFAS patients had significant apoptosis defects in these cells compared to healthy controls. Hence, this rapid apoptosis assay can expedite the diagnosis of new ALPS patients, including those with somatic mutations, and facilitate clinical and molecular investigation of these diseases.

KW - Apoptosis

KW - Autoimmune Lymphoproliferative syndrome

KW - Diagnosis

KW - Double-negative Tcells

KW - Effectormemory Tcells

KW - Fas

UR - http://www.scopus.com/inward/record.url?scp=84879882746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84879882746&partnerID=8YFLogxK

U2 - 10.1007/s10875-012-9811-z

DO - 10.1007/s10875-012-9811-z

M3 - Article

VL - 33

SP - 479

EP - 488

JO - Journal of Clinical Immunology

JF - Journal of Clinical Immunology

SN - 0271-9142

IS - 2

ER -